# Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms

> **NCT05626504** · — · UNKNOWN · sponsor: **King's College Hospital NHS Trust** · enrollment: 50 (estimated)

## Conditions studied

- Brain Aneurysm
- Intracranial Hemorrhages
- Stroke

## Interventions

- **DEVICE:** Pipeline Embolization Device with Vantage Technology

## Key facts

- **NCT ID:** NCT05626504
- **Lead sponsor:** King's College Hospital NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-27
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-03-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05626504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05626504, "Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05626504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*